Tg Therapeutics (TGTX) Non Operating Investment Income (2011)

Tg Therapeutics (TGTX) recorded quarterly Non Operating Investment Income of -$2.1 million in Q3 2011, up 5.86% quarter-over-quarter from -$2.2 million in Q2 2011.

Tg Therapeutics (TGTX) Non Operating Investment Income (2011) Analysis & Trends

Tg Therapeutics' Non Operating Investment Income history runs 1 years deep, the most recent figure standing at -$2.1 million for Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 235,807.00
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 230,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Tg Therapeutics 7.71 Bn 7.06 Bn 171.41 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2011 -2.10 Mn
Sep 30, 2011 -2.10 Mn
Jun 30, 2011 -2.23 Mn
Jun 30, 2011 -2.23 Mn